The CBSE Class 12 Biology exam is scheduled for March 27, 2026. Experts advise students to focus on key topics like Genetics, ...

Are you a Class 10 student looking for quick revision notes? Keep following this space for more such quick notes and sample ...

The authority examined whether plastic filter tips used with automated instruments were machine parts and held they were disposable consumables, classifiable as articles of plastic under CTH ...

ICSE Biology Specimen Paper 2026 for Class 10: The ICSE Biology Specimen Paper 2026 exam will be held on 13 March 2026, and students appearing for the CISCE Class 10 Board Exam are highly encouraged ...

The Council for the Indian School Certificate Examinations (CISCE) has released the structured exam pattern for the ICSE Class 10 Biology 2026 Board Exam, which is crucial for students aiming to ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...

Drew Swanson is a Features Article Editor from the Pacific Northwest of the United States. He is a lifelong gamer with a passion for a variety of genres. A connoisseur of everything from JRPGs and ...

You’ll start this chapter on a motorcycle, with Jessie at your back and Biggs and Wedge on another motorcycle. Ride along the tunnel for a while and get used to the controls and Shinra will attack.

Akebia Therapeutics has struck a deal for Q32 Bio’s deprioritized complement inhibitor ADX-097, paying $7 million upfront for an asset that forms the centerpiece of its new rare kidney disease ...

Borderlands 4 isn't quite a live service game, but its endgame does heavily revolve around a weekly schedule. This weekly update rotates endgame content, shifts the location of Maurice's Black Market ...

Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of ...

) has been revised to $10.65 / share. This is an increase of 12.48% from the prior estimate of $9.47 dated November 14, 2025. The price target is an average of many targets provided by analysts. The ...